Veterinary Diagnostics: Disease Threats to Animals Will Boost Need for New Tests

There are many diseases that can affect cattle, pigs and other livestock and

endanger the food supply. Swine fever, neosporosis, foot-and-mouth

disease and other diseases are among the threats to animals that humans

eat. Test makers have answered the call to develop products that can help

food manufacuters and government agencies protect livestock and ensure a

safe food supply at the beginning of the chain. For this reason, the

Veterinary Diagnostics market can expect healthy revenue growth

according to a recent Kalorama Information report on the topic. It’s a less

regulated area than human clinical IVD, and companies that make diagnostic products have been attracted by the

faster approval times and in some cases higher profit margins. While of the two sub markets within this market pet

diagnostics is stronger in terms of growth than food animal diagnostics. Kalorama still thinks food animal

diagnostics will drive growth in the market.

It’s hard to predict animal disease, but a lot is going on in this market. Emerging nations are beginning disease

control and eradication programs and this will boost global markets for food animal diagnostics. There’s another

factor – new products to test animals. The penetration of easy-to-use molecular diagnostic test kits for veterinary

infectious diseases also represents another factor improving the value of the global food animal diagnostics market.

U.S. veterinary diagnostics have predominated in the companion animal or pet segment. Since 2012, new market

players for animal tests in the United States – Biogal/Galed Laboratories, Princeton BioMeditech, and InBios –

launched tests for canine distemper, canine heartworm, and West Nile virus. to the significantly wider portfolio

of livestock disease tests.

Europe has seen more food animal testing, where several disease eradication programs boosted livestock testing in

the past decade. Kalorama found 14 livestock infectious disease tests in the US delisted (as part of portfolio

management or company withdrawal from the market) and 9 introduced (in most cases with competitive tests

already on the market). So that’s more tests off the market than on. Three of the tests removed were from vendors

still offering a “me too” test – a test for the same target disease. The near equal rates of product addition and attrition

indicate a largely flat market for U.S. livestock infectious disease diagnostics. Market growth is predicated upon

disease outbreaks and management; the United States has seen no recent, market-significant outbreaks and active

disease eradication programs have focused overwhelmingly on industry practices and vaccination.

NEW FROM Kalorama Information

Veterinary Diagnostics Markets Complete Estimates and Forecasts of the

Animal Testing Market